Latest Market Development News

Site Group International edges closer to securing a pivotal Higher Training Institute license in Saudi Arabia, while reporting a robust 112% revenue surge and completing a $1 million capital raise to fuel expansion.

Electro Optic Systems (EOS) has completed the divestment of its EM Solutions subsidiary for $158.6 million, wiping out all borrowings and positioning itself with a strong cash balance of approximately $128 million. The company is actively pursuing significant defence contracts and expanding its manufacturing footprint.

Visioneering Technologies reported a mixed Q4 FY'24 with a slight revenue decline but stronger cash flow and expanding global footprint, underpinned by promising clinical trial data.

Berkeley Energia reports promising lithium and rubidium mineralisation at its Conchas Project while advancing a $1 billion arbitration claim against Spain over regulatory setbacks at Salamanca.

Percheron Therapeutics has terminated its phase IIb avicursen trial for Duchenne muscular dystrophy after failing to meet efficacy endpoints, while securing $14.85 million in fresh capital to explore new therapeutic opportunities.

SportsHero Limited has inked a five-year partnership with Indonesia's Indosat Ooredoo Hutchison to market its Family Game Room product, alongside securing a $1 million debt facility to support its expansion plans.

Radiopharm Theranostics has secured key ethics approvals to expand its clinical trial portfolio, completed significant preclinical milestones, and raised A$8 million through a strategic placement, while maintaining its cash runway to mid-2026.

Murray Cod Australia Ltd has secured a $43 million funding package from Westpac, advancing its Stanbridge site construction and expanding its biomass. The company also initiated exports to Thailand and is progressing towards entry into the Chinese market.

Atomo Diagnostics reports a robust Q2 FY25 with $1.2 million revenue driven by HIV self-test sales and a significant $2.44 million government grant for syphilis test development. The company advances its market footprint in Australia and New Zealand while maintaining a strong cash position.

Arrow Minerals Limited has addressed a recent spike in its share price, attributing the rise to positive operational developments and a buoyant bauxite market, while confirming plans for a confidential capital raising.

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.

Foresta Group Holdings has raised $3.1 million through a convertible note and share placement, while securing exclusive technology licensing and key offtake agreements to propel its flagship New Zealand biomass project.